Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-25 @ 9:32 PM
Study NCT ID:
NCT05459051
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2022-07-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Finding the Invasive Haemodynamic Threshold for Symptom Relief in Stable Angina
Sponsor:
Imperial College London
Organization:
Study Overview
Official Title:
Finding the Invasive Haemodynamic Threshold for Symptom Relief in Stable Angina
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ORBITA-FIRE
Brief Summary:
ORBITA-FIRE is a randomised, double-blinded, placebo controlled experimental study that will identify the fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) thresholds that correlate with symptoms of angina for 58 patients measured invasively under experimental conditions.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 22HH7546 | OTHER | Imperial College London | View |